investorscraft@gmail.com

Investing in Haemonetics Corporation (HAE)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)1.65-98
Intrinsic value (DCF)1.81-98
Graham-Dodd Method12.94-85
Graham Formula77.60-13

Company description

Haemonetics Corporation (HAE) is a global healthcare company that specializes in blood management solutions. Founded in 1971, the company has a rich history in developing and providing innovative products and services to improve the safety and efficacy of blood transfusions. With a presence in over 50 countries, HAE is a leading provider of blood collection, processing, and transfusion technologies for healthcare organizations around the world. The company's comprehensive portfolio includes devices, software, and services that enable healthcare professionals to collect and process blood, manage inventories, and track patient outcomes. HAE is committed to advancing the science of blood management through cutting-edge research and development, and strives to continuously improve patient outcomes by reducing the risks associated with blood transfusions. In addition to its focus on delivering high-quality products and services, HAE is dedicated to sustainability and strives to minimize its environmental impact through responsible practices. With a strong global presence, innovative solutions, and a commitment to improving patient care and outcomes, HAE is a trusted and respected leader in the healthcare industry.
HomeMenuAccount